LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Nov 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-11-02

Reporting Person: Smith Robin L (Director, Chairman of Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-02	Common Stock, $0.001 par value	A	268664	$0.62	Acquired	1332750	Direct

Footnotes

F1: On November 2, 2011, the Compensation Committee of the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive the net amount of her contractual bonus due October 1, 2011, through the issuance to her by the Issuer of shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), at the closing price of the Common Stock on November 1, 2011, under and subject to the terms and conditions of the Issuer's 2009 Equity Compensation Plan.